Lv3
290 积分 2023-08-27 加入
Prohormone cleavage prediction uncovers a non-incretin anti-obesity peptide
10小时前
已完结
Unconventional insulins from predators and pathogens
4天前
已完结
Discovery of novel OXM-based glucagon-like peptide 1 (GLP-1)/glucagon receptor dual agonists
4天前
已完结
Novel glucagon- and OXM-based peptides acting through glucagon and GLP-1 receptors with body weight reduction and anti-diabetic properties
5天前
已完结
Emerging roles of oxyntomodulin-based glucagon-like peptide-1/glucagon co-agonist analogs in diabetes and obesity
5天前
已完结
Discovery of a potent and long-acting Xenopus GLP-1-based GLP-1/glucagon/Y2 receptor triple agonist
6天前
已完结
Emerging roles of oxyntomodulin-based glucagon-like peptide-1/glucagon co-agonist analogs in diabetes and obesity
6天前
已完结
Sustained release of GLP-1 analog from γ-PGA-PAE copolymers for management of type 2 diabetes
7天前
已完结
Towards a unifying model for B-cell receptor triggering
11天前
已完结
A Novel Fc-FGF21 With Improved Resistance to Proteolysis, Increased Affinity Toward β-Klotho, and Enhanced Efficacy in Mice and Cynomolgus Monkeys
12天前
已完结
皖公网安备34019202002308
